Mitoxantrone Terminated Phase 2 Trials for Leukemias Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00268242Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia